2020-CL-0102 (Evolve)

2020-CL-0102 (Evolve)

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

This study is a research study that watches how a vision problem changes over time. The condition is called Stargardt disease or Stargardt type macular dystrophy, which affects how well a person can see. Researchers will follow people with this condition and collect information to learn how vision changes. The goal is to better understand the disease so doctors can improve care and treatment in the future.

Who Can Participate?

Eligibility

People can join this study if they are 18 years old or older and have been diagnosed with a vision disease called Stargardt disease or a similar condition that affects the back of the eye. They cannot join if they have uncontrolled glaucoma, which is a serious eye disease that can damage vision.

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

This study is a research study that watches how a vision problem changes over time. The condition is called Stargardt disease or Stargardt type macular dystrophy, which affects how well a person can see. Researchers will follow people with this condition and collect information to learn how vision changes. The goal is to better understand the disease so doctors can improve care and treatment in the future.

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

An Observational Study of Natural Disease Progression in Participants with Macular Dystrophies Expressing a Stargardt-type Clinical Presentation - (Evolve)

Principal Investigator

Oleg
Alekseev

Protocol Number

PRO00119889

NCT ID

NCT07425574

Phase

N/A

Enrollment Status

Open to Enrollment